LESS RESEARCH FUNDING MEANS MORE LIVES LOST. Help us keep funding research that saves lives. Donate Now
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Pancreatic Neuroendocrine Tumor (NET)
Pancreatic neuroendocrine tumors (pNETs) are hard to find early. The pancreas is deep inside the body, so health care providers can't see or feel the tumors during routine physical exams. People usually have no symptoms until the cancer has already spread to other organs.
At this time, no major professional groups recommend routine screening for pNET in people who are at average risk. This is because no screening test has been shown to lower the risk of dying from this cancer. (Screening means testing for a disease in people who have no symptoms or history of the disease.)
Some people might have a higher risk of pNET because of a family history of the disease (or a family history of certain other cancers). Sometimes this increased risk is from a specific genetic syndrome.
Some of the gene changes that increase pNET risk can be tested for. Knowing if you are at increased risk can help you and your doctor decide if you should have tests to look for pNET early when treatment might be more successful. But determining if you might be at increased risk is not simple. Talking to someone with experience in hereditary cancer syndromes such as a genetic counselor, geneticist, or an oncologist (doctor who treats people with cancer) is often helpful.
The American Cancer Society strongly recommends that anyone thinking about genetic testing talk with a genetic counselor, nurse, or doctor qualified to interpret and explain the test results before they proceed with testing. Before deciding to be tested, it’s important to understand what the tests can − and can’t − show you, and what any results might mean.
Genetic tests look for mutations in your genes that cause inherited conditions. The tests are used to look for these inherited conditions, not the cancer itself. Your risk may be increased if you have one of these conditions, but it doesn’t mean that you have or definitely will get pancreatic NET.
For people in families at high risk of pNET, such as those with MEN1 syndrome (increases the risk of pancreas, pituitary, and parathyroid tumors), tests for detecting cancer early may help. Although definitive screening guidelines for people with the MEN1 gene or their family members are not available, doctors have been able to find early, treatable pNETs in some members of high-risk families with these tests. Some tests that might be considered include:
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Arnold A. Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis. UpToDate website. https://www.uptodate.com/contents/multiple-endocrine-neoplasia-type-1-clinical-manifestations-and-diagnosis Updated: Jul 24, 2017. Accessed October 3, 2018.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal Tumors. V.3.2018. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdfon October 8, 2018.
Vinik A, Perry RR, Hughes MS, et al. Multiple Endocrine Neoplasia Type 1. [Updated 2017 Oct 7]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK481897/. Accessed October 2, 2018.
Last Revised: March 29, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.